161 related articles for article (PubMed ID: 24720467)
1. Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: a large case-control study and meta-analysis.
Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
Autoimmunity; 2014 Sep; 47(6):383-8. PubMed ID: 24720467
[TBL] [Abstract][Full Text] [Related]
2. Relationship between chemokine receptor 5 Δ32/W gene polymorphism and lupus nephritis.
Zhou TB; Jiang ZP; Zhou JF; Su N
Hum Immunol; 2014 Sep; 75(9):968-72. PubMed ID: 25167769
[TBL] [Abstract][Full Text] [Related]
3. Association between chemokine receptor 5 delta32 polymorphism and susceptibility to cancer: a meta-analysis.
Lee YH; Song GG
J Recept Signal Transduct Res; 2015; 35(6):509-15. PubMed ID: 25203595
[TBL] [Abstract][Full Text] [Related]
4. Chemokine receptor 5 Δ32 polymorphism and systemic lupus erythematosus, vasculitis, and primary Sjogren's syndrome. Meta-analysis of possible associations.
Lee YH; Kim JH; Song GG
Z Rheumatol; 2014 Nov; 73(9):848-55. PubMed ID: 24599359
[TBL] [Abstract][Full Text] [Related]
5. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.
Sandford B; Bown M; London N; Sayers R
Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483
[TBL] [Abstract][Full Text] [Related]
6. Lack of association of C-C chemokine receptor 5 Δ32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity.
Martens HA; Gross S; van der Steege G; Brouwer E; Berden JH; de Sevaux R; Derksen RH; Voskuyl AE; Berger SP; Navis GJ; Kallenberg CG; Bijl M
J Rheumatol; 2010 Nov; 37(11):2226-31. PubMed ID: 20682662
[TBL] [Abstract][Full Text] [Related]
7. Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC; Song GG
Mod Rheumatol; 2013 Mar; 23(2):304-10. PubMed ID: 22638733
[TBL] [Abstract][Full Text] [Related]
8. Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
Prahalad S
Genes Immun; 2006 Apr; 7(3):264-8. PubMed ID: 16541097
[TBL] [Abstract][Full Text] [Related]
9. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
[TBL] [Abstract][Full Text] [Related]
11. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility.
Srivastava A; Pandey SN; Choudhuri G; Mittal B
Scand J Immunol; 2008 May; 67(5):516-22. PubMed ID: 18405329
[TBL] [Abstract][Full Text] [Related]
12. CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus.
Mamtani M; Rovin B; Brey R; Camargo JF; Kulkarni H; Herrera M; Correa P; Holliday S; Anaya JM; Ahuja SK
Ann Rheum Dis; 2008 Aug; 67(8):1076-83. PubMed ID: 17971457
[TBL] [Abstract][Full Text] [Related]
13. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
[TBL] [Abstract][Full Text] [Related]
14. Effect of CCR5-Δ32 heterozygosity on HIV-1 susceptibility: a meta-analysis.
Liu S; Kong C; Wu J; Ying H; Zhu H
PLoS One; 2012; 7(4):e35020. PubMed ID: 22496885
[TBL] [Abstract][Full Text] [Related]
15. A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
Song GG; Lee YH
Immunol Invest; 2014; 43(4):299-311. PubMed ID: 24295368
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis.
Brajão de Oliveira K; Reiche EM; Kaminami Morimoto H; Pelegrinelli Fungaro MH; Estevão D; Pontello R; Franco Nasser T; Watanabe MA
J Cutan Pathol; 2007 Jan; 34(1):27-32. PubMed ID: 17214851
[TBL] [Abstract][Full Text] [Related]
17. Protective role for CCR5 in murine lupus nephritis.
Turner JE; Paust HJ; Bennstein SB; Bramke P; Krebs C; Steinmetz OM; Velden J; Haag F; Stahl RA; Panzer U
Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1503-15. PubMed ID: 22442210
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of CCR5-delta32 mutation in asthmatic and non-asthmatic subjects from department of medicine, JUCM, Cracow.
Gomulska M; Rusin G; Gwiazdak P
Folia Med Cracov; 2014; 54(4):5-13. PubMed ID: 25891238
[TBL] [Abstract][Full Text] [Related]
19. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between chemokine receptor 5 (CCR5) δ32 mutation and pathogenesis of asthma in Iranian patients.
Abousaidi H; Vazirinejad R; Arababadi MK; Rafatpanah H; Pourfathollah AA; Derakhshan R; Daneshmandi S; Hassanshahi G
South Med J; 2011 Jun; 104(6):422-5. PubMed ID: 21886032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
